Quest Diagnostics (DGX) Gains From New M&As Amid Competition
Yahoo Finance · 2 days ago
Open | 138.64 |
High | 139.69 |
Low | 137.90 |
Mkt Cap | 15.44B |
P/E (TTM) | 18.70 |
Div & Yield | 3.00 & 2.16% |
Prev. Close | 138.20 |
52 Wk. Low | 119.59 |
52 Wk. High | 145.62 |
Related stocks
Medical research company
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 2.37B | 1.50% ▲ |
Net Income | 194M | 4.00% ▼ |
Diluted EPS | 2.04 | 3.40% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.33 | - |
Q1 2024 | $1.85 | $2.04 |
Q4 2023 | $2.11 | $2.15 |
S&P 500^GSPC | 5,464.62-8.55 (-0.16%) |
Dow 30^DJI | 39,150.33+15.57 (+0.04%) |
Nasdaq^IXIC | 17,689.36-32.23 (-0.18%) |
Duolingo, Inc.DUOL | 206.52+3.73% |
Netflix, Inc.NFLX | 686.12+1.04% |
58.88+0.98% |